Investigation of the Underlying Mechanism of Huangqi-Dangshen for Myasthenia Gravis Treatment via Molecular Docking and Network Pharmacology

Table 3

Topological parameter analysis of key targets.

Name	Closeness	Betweenness	Degree
EGFR	155.91667	21055.22881	87
CASP3	138.91667	13581.81055	61
IL6	136.0	11100.0022	53
FOS	132.66667	9254.88492	50
ESR1	127.58333	5203.38585	47
AR	123.5	6788.10848	45
MYC	121.5	2737.21043	26
ICAM1	104.66667	1694.87097	26
ESR2	110.83333	866.28027	19
BIRC5	104.35	2468.86776	18
NR3C1	111.35	1192.98489	17
TP53	116.85	795.40972	12
STAT3	117.18333	1038.66281	12
HSPB1	106.68333	1341.56512	10
SRC	110.66667	3322.67413	8
MAPK14	113.01667	266.80844	8
JUN	117.58333	5100.94748	8
TNF	112.35	704.28349	8
VEGFA	110.01667	982.86802	8
RELA	105.51667	314.52161	8
MAPK1	111.01667	249.58642	7
MAPK3	111.01667	249.58642	7
MAPK8	108.35	247.61036	7